LNC vs MORN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LNC presents as a classic value trap, characterized by a critically weak Piotroski F-Score of 2/9, indicating severe deterioration in fundamental financial health. While the stock trades at a significant discount to its Graham Number ($82.75) and slightly below its intrinsic value ($40.81), this valuation is offset by negative YoY revenue and earnings growth. Bearish insider activity and a 0/100 technical trend further signal a lack of confidence in a near-term recovery. Despite a sustainable dividend payout ratio, the underlying operational decay makes the current price a risky entry point.
MORN exhibits a mediocre Piotroski F-Score of 4/9, indicating stable but non-improving financial health. The stock is trading at a significant premium to both its Graham Number ($79.65) and its growth-based Intrinsic Value ($126.09), suggesting severe overvaluation. This fundamental weakness is compounded by a 0/100 technical trend and aggressive insider selling totaling over $25M. While profitability remains strong with a 26.35% ROE, the lack of price momentum and valuation gap outweigh the operational strengths.
Compare Another Pair
Related Comparisons
LNC vs MORN: Head-to-Head Comparison
This page compares Lincoln National Corporation (LNC) and Morningstar, Inc. (MORN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.